Diversified Healthcare Trust (DHC) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
19 Mar, 2026Executive summary
Focused on strategic initiatives in 2025, including capital recycling, balance sheet strengthening, and operational improvements, particularly in the senior housing operating portfolio (SHOP).
Transitioned 116 SHOP communities to new operators, aiming for improved occupancy, rental rates, and NOI growth over the next fiscal year.
Achieved total shareholder returns of 113% in 2025, ranking first among U.S. REITs.
Ended 2025 with no debt maturities until 2028, $4 billion in unencumbered assets, and $255 million in liquidity.
Completed $605 million in non-core asset dispositions in 2025, with further dispositions planned for early 2026.
Voting matters and shareholder proposals
Shareholders will vote on electing seven trustee nominees, an advisory say-on-pay vote for executive compensation, and ratification of Deloitte & Touche LLP as independent auditors for 2026.
Board recommends voting for all trustee nominees and for both executive compensation and auditor ratification.
Shareholders can submit proposals for the 2027 annual meeting by November 19, 2026, with proxy access and advance notice provisions detailed in the bylaws.
Board of directors and corporate governance
Board consists of seven members: five independent trustees and two managing trustees.
Board composition emphasizes diversity, financial literacy, governance, and industry expertise.
Annual elections for all trustees; proxy access bylaw in place; resignation policy for trustees not receiving majority votes.
Lead Independent Trustee role with defined responsibilities; all committees comprised solely of independent trustees.
Regular shareholder engagement and annual board/committee evaluations.
Latest events from Diversified Healthcare Trust
- Updated sustainability metrics and climate risk strategies underscore ongoing ESG leadership.DHC
Proxy filing25 Mar 2026 - Trustee elections, executive pay, and auditor ratification headline the June 2026 meeting.DHC
Proxy filing19 Mar 2026 - Record NOI growth, margin expansion, and debt reduction drive strong shareholder returns.DHC
Q4 202524 Feb 2026 - Record 2025 returns, SHOP growth, and capital recycling drive strong outlook for 2026.DHC
Investor presentation24 Feb 2026 - Q1 2025 delivered 4.3% revenue growth, narrowed net loss, and strong SHOP segment gains.DHC
Q1 20255 Feb 2026 - Q3 2025 revenue up, SHOP improved, but net loss rose on impairments and transitions.DHC
Q3 20255 Feb 2026 - Q4 revenue up 5%, SHOP NOI up 56%, and a $7.2B portfolio supports debt reduction.DHC
Q4 20245 Feb 2026 - SHOP segment drives NOI growth, but net loss widens amid asset sales and cost pressures.DHC
Q3 20245 Feb 2026 - Q2 2024 delivered strong SHOP NOI growth and higher revenues despite a wider net loss.DHC
Q2 20245 Feb 2026